Reducing atherosclerotic cardiovascular disease risk: A focus on lipid lowering drugs
In the ensuing piece, l will be using lots of materials from Wilkinson et al. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalised Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. J. Am. Heart Assoc 2023.
Cardiovascular disease (CVD) is a leading cause of death globally. In 2020,…